Published in Naunyn Schmiedebergs Arch Pharmacol on March 01, 1982
Actions of noradrenaline recorded intracellularly in rat hippocampal CA1 pyramidal neurones, in vitro. J Physiol (1986) 1.69
The effects of methylphenidate on cognitive performance of healthy male rats. Front Neurosci (2013) 0.76
Atmospheric carbon dioxide concentrations over the past 60 million years. Nature (2000) 5.69
Dopamine neuron agenesis in Nurr1-deficient mice. Science (1997) 5.40
Defects in enteric innervation and kidney development in mice lacking GDNF. Nature (1996) 3.82
Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci U S A (2001) 2.73
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature (1995) 2.69
Functional recovery in parkinsonian monkeys treated with GDNF. Nature (1996) 2.35
How does adenosine inhibit transmitter release? Trends Pharmacol Sci (1988) 2.20
Widespread dissemination of metal debris from implants. J Bone Joint Surg Br (1994) 2.19
Allosteric control of gating and kinetics at P2X(4) receptor channels. J Neurosci (1999) 2.10
Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J Neurosci (1998) 1.99
Variable fitness effects of Wolbachia infection in Drosophila melanogaster. Heredity (Edinb) (2004) 1.88
Lack of Fc-epsilon receptors on murine eosinophils: implications for the functional significance of elevated IgE and eosinophils in parasitic infections. Blood (1997) 1.86
Local circuit interactions between oriens/alveus interneurons and CA1 pyramidal cells in hippocampal slices: electrophysiology and morphology. J Neurosci (1987) 1.83
Ethanol increases the firing rate of dopamine neurons of the rat ventral tegmental area in vitro. Brain Res (1990) 1.81
Adenine nucleotides and synaptic transmission in the in vitro rat hippocampus. Br J Pharmacol (1980) 1.78
Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science (1979) 1.74
The physiological role of adenosine in the central nervous system. Int Rev Neurobiol (1985) 1.71
Synaptic potentials mediated via alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. J Neurosci (1998) 1.66
Activation of the pathway from locus coeruleus to rat cerebellar Purkinje neurons: pharmacological evidence of noradrenergic central inhibition. J Pharmacol Exp Ther (1973) 1.55
Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. II. Sensitivity of Purkinje cells to norepinephrine and related substances administered by microiontophoresis. Brain Res (1971) 1.55
Mechanism of action of ethanol: initial central nervous system actions. Pharmacol Rev (1989) 1.52
Heteropodatoxins: peptides isolated from spider venom that block Kv4.2 potassium channels. Mol Pharmacol (1997) 1.52
Activation of a central noradrenergic projection to cerebellum. Nature (1971) 1.48
Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. J Neurosci (1997) 1.48
Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res (2001) 1.46
Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res (1993) 1.40
Activity-dependent release of endogenous adenosine modulates synaptic responses in the rat hippocampus. J Neurosci (1993) 1.39
Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. J Pharmacol Exp Ther (1990) 1.37
Ethanol sensitivity of the GABAA receptor expressed in Xenopus oocytes requires 8 amino acids contained in the gamma 2L subunit. Neuron (1991) 1.36
Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. 3. Evidence for mediation of norepinephrine effects by cyclic 3',5'-adenosine monophosphate. Brain Res (1971) 1.36
Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. J Pharmacol Exp Ther (1982) 1.33
The dextro and levorotatory isomers of N-phenylisopropyladenosine: stereospecific effects on cyclic AMP-formation and evoked synaptic responses in brain slices. Life Sci (1979) 1.32
Cyclic adenosine monophosphate: possible mediator for norepinephrine effects on cerebellar Purkinje cells. Science (1969) 1.26
Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc Natl Acad Sci U S A (1995) 1.24
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol (1989) 1.24
Adenosine increases synaptic facilitation in the in vitro rat hippocampus: evidence for a presynaptic site of action. J Physiol (1985) 1.24
A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra. Exp Neurol (2006) 1.23
Antagonists of the receptor-G protein interface block Gi-coupled signal transduction. J Biol Chem (1998) 1.22
Bone morphogenetic protein-7 reduces toxicity induced by high doses of methamphetamine in rodents. Neuroscience (2007) 1.22
Vitamin D(3) attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology (2000) 1.20
Postnatal development of electrical and enzyme histochemical activity in Purkinje cells. Exp Neurol (1969) 1.19
Microiontophoretic release of norepinephrine from micropipettes. Neuropharmacology (1971) 1.19
Studies on norepinephrine-containing afferents to Purkinje cells of art cerebellum. I. Localization of the fibers and their synapses. Brain Res (1971) 1.18
Presynaptic inhibition of excitatory synaptic transmission by adenosine in rat hippocampus: analysis of unitary EPSP variance measured by whole-cell recording. J Neurosci (1992) 1.14
Endogenously released adenosine regulates excitability in the in vitro hippocampus. Epilepsia (1980) 1.14
Development of hyperpolarizing inhibitory postsynaptic potentials and hyperpolarizing response to gamma-aminobutyric acid in rabbit hippocampus studied in vitro. J Neurosci (1984) 1.14
Characteristics of hippocampal primed burst potentiation in vitro and in the awake rat. J Neurosci (1988) 1.13
A method for detecting intracellular cyclic adenosine monophosphate by immunofluorescence. J Histochem Cytochem (1972) 1.12
Differential ethanol sensitivity of subpopulations of GABAA synapses onto rat hippocampal CA1 pyramidal neurons. J Neurophysiol (1997) 1.11
The ontogenetic development of synaptic junctions, synaptic activation and responsiveness to neurotransmitter substances in rat cerebellar purkinje cells. Brain Res (1971) 1.11
In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions. Exp Neurol (2001) 1.10
Temperature-dependent modulation of excitatory transmission in hippocampal slices is mediated by extracellular adenosine. J Neurosci (1999) 1.10
The relationship between extracellular calcium concentrations and the induction of hippocampal long-term potentiation. Brain Res (1979) 1.09
Induction of hippocampal long-term potentiation using physiologically patterned stimulation. Neurosci Lett (1986) 1.08
Adenosine receptors mediating inhibitory electrophysiological responses in rat hippocampus are different from receptors mediating cyclic AMP accumulation. Naunyn Schmiedebergs Arch Pharmacol (1984) 1.08
Bone morphogenetic protein-6 reduces ischemia-induced brain damage in rats. Stroke (2001) 1.08
Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system. Cell Tissue Res (1996) 1.08
Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis. J Pharmacol Exp Ther (1996) 1.07
Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease. Brain Res (2004) 1.06
Modulation of excitatory synaptic transmission by adenosine released from single hippocampal pyramidal neurons. J Neurosci (1996) 1.03
Modulatory actions of norepinephrine in the central nervous system. Fed Proc (1979) 1.03
Systemic administration of a nerve growth factor conjugate reverses age-related cognitive dysfunction and prevents cholinergic neuron atrophy. J Neurosci (1996) 1.03
Benzodiazepines and central inhibitory mechanisms. Naunyn Schmiedebergs Arch Pharmacol (1978) 1.03
Nigrostriatal function in humans studied with positron emission tomography. Ann Neurol (1989) 1.03
Alkylxanthines elevate hippocampal excitability. Evidence for a role of endogenous adenosine. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.02
Multiple single-unit recordings in the striatum of freely moving animals: effects of apomorphine and D-amphetamine in normal and unilateral 6-hydroxydopamine-lesioned rats. Brain Res (1999) 1.02
Adenosine inhibits calcium spikes in hippocampal pyramidal neurons in vitro. Neurosci Lett (1983) 1.02
Opioid inhibition in locus coeruleus. J Neurophysiol (1995) 1.02
alpha7 nicotinic acetylcholine receptors on GABAergic interneurons evoke dendritic and somatic inhibition of hippocampal neurons. J Neurophysiol (2002) 1.02
GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area. J Comp Neurol (2001) 1.01
Effects of serotonin on central neurons: microiontophoretic administration. Fed Proc (1972) 1.01
Cyclic adenosine monophosphate and norepinephrine: effects on transmembrane properties of cerebellar Purkinje cells. Science (1971) 1.01
Role of adenosine as a modulator of synaptic activity in the central nervous system. Adv Pharmacol (1997) 1.00
A selective group of dopaminergic neurons express Nurr1 in the adult mouse brain. Brain Res (1999) 1.00
Cyclic AMP-mediated adrenergic synapses to cerebellar Purkinje cells. Adv Cyclic Nucleotide Res (1972) 1.00
Glial cell line-derived neurotrophic factor receptor alpha1 availability regulates glial cell line-derived neurotrophic factor signaling: evidence from mice carrying one or two mutated alleles. Neuroscience (2000) 1.00
Interaction of norepinephrine with cerebellar activity evoked by mossy and climbing fibers. Exp Neurol (1977) 0.99
Transgenic rodent models of Parkinson's disease. Acta Neurochir Suppl (2008) 0.99
A quantitative microiontophoretic analysis of the responses of central neurones to noradrenaline: interactions with cobalt, manganese, verapamil and dichloroisoprenaline. Br J Pharmacol (1975) 0.98
Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: long-term behavioral, biochemical, and histochemical studies. Ann Neurol (1980) 0.98
Levels of adenosine and adenine nucleotides in slices of rat hippocampus. Brain Res (1984) 0.98
Electrophysiological response of cerebellar Purkinje neurons to leukotriene D4 and B4. J Pharmacol Exp Ther (1981) 0.98
Osteogenic protein-1 protects against cerebral infarction induced by MCA ligation in adult rats. Stroke (1999) 0.98
Ethanol differentially enhances hippocampal GABA A receptor-mediated responses in protein kinase C gamma (PKC gamma) and PKC epsilon null mice. J Pharmacol Exp Ther (2003) 0.98
Interactions between the effects of adenosine and calcium on synaptic responses in rat hippocampus in vitro. J Physiol (1984) 0.97
Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J Comp Neurol (1995) 0.97
HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury. Exp Neurol (2003) 0.97
Characteristics of the release of adenosine 3':5'-monophosphate from micropipets by microiontophoresis. J Cyclic Nucleotide Res (1975) 0.97
Cocaine effects in the ventral tegmental area: evidence for an indirect dopaminergic mechanism of action. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.96
Beta adrenergic sensitization of gamma-aminobutyric acid receptors to ethanol involves a cyclic AMP/protein kinase A second-messenger mechanism. J Pharmacol Exp Ther (1997) 0.96
An alternative Fc gamma-receptor ligand: potential role in T-cell development. Proc Natl Acad Sci U S A (1994) 0.96
Cellular and developmental patterns of expression of Ret and glial cell line-derived neurotrophic factor receptor alpha mRNAs. Exp Brain Res (1997) 0.96
Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp Brain Res (1997) 0.96
Dissociation of mu and delta opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro. Brain Res (1992) 0.95
Characterization of the techniques of pressure ejection and microiontophoresis using in vivo electrochemistry. J Neurosci Methods (1987) 0.95